GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » Change In Working Capital

Sipai Health Technology Co (HKSE:00314) Change In Working Capital : HK$-37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co Change In Working Capital?

Sipai Health Technology Co's change in working capital for the quarter that ended in Dec. 2023 was HK$89 Mil.

Sipai Health Technology Co's change in working capital for the fiscal year that ended in Dec. 2023 was HK$-37 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


Sipai Health Technology Co Change In Working Capital Historical Data

The historical data trend for Sipai Health Technology Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co Change In Working Capital Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
Change In Working Capital
-301.14 85.23 -36.91

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Change In Working Capital - -89.86 170.84 -126.18 89.27

Sipai Health Technology Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-37 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (HKSE:00314) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Jeneration Group Limited 2201 Interest of corporation controlled by you
Leung Catherine Ho Yan 2202 Interest of your spouse
Purple Panther 2201 Interest of corporation controlled by you
Ma Xuguang 2501 Other
Li Ji 2501 Other
Wise Approach Investments Limited 2101 Beneficial owner
Ark Trust (hong Kong) Limited 2301 Trustee
Jpmorgan Chase & Co. 2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd. 2101 Beneficial owner
Simul International Holdings Limited 2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines